E-DRUG: Product Alert N° 2/2017 Falsified Quinine Sulphate circulating in Africa
------------------------------------------------------------------------------------------------
This Medical Product Alert relates to the circulation of two confirmed
falsified versions of Quinine Sulphate, in the Democratic Republic of the
Congo, and containing zero active pharmaceutical ingredient.
Quinine Sulphate is used for the treatment of Falciparum Malaria in the
region.
In April 2017, a local NGO discovered these products in pharmacies in the
north-east of the Democratic Republic of the Congo. The products were
submitted to laboratory testing with a WHO pre-qualified Quality Assurance
laboratory. This analysis showed that the two products did not contain any
of the stated active pharmaceutical ingredient.
The manufacturers indicated on the label of both products, Remedica and
Laboratory&Allied, have stated that they did not manufacture these specific
products: the variable details on the product label do not correspond to
the genuine manufacturer records.
Details and photographs of both products are shown below:
http://www.who.int/medicines/publications/drugalerts/drug_alert2-2017/en/
Bruneton Carinne
E-med and E-DRUG
<carinne.bruneton@gmail.com>